Left Ventricular Hypertrophy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA label_change · 2020-08-20
FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) filed by Organon LLC, resulting in changes t…